Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Enrolling by invitation  
  • Page 1 ·  Next »

NCT ID: NCT03243448 Enrolling by invitation - Healthy Clinical Trials

Skin Sympathetic Nerve Activity and Sympathetic Tone

Start date: August 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

There are many sympathetic hyperactivity diseases in the investigators' clinical practice. However, the conventional method to measure the sympathetic nerve activity had many limitations such as clinical application, data interpretation and even therapeutic manipulation. Therefore the investigators would like to develop a non-invasive method to record the sympathetic nerve activity in the investigators' study that can help gathering the sympathetic nerve activity easily in the investigators' daily clinical situation. By the determination of sympathetic nerve activity status, the health caregiver can understand the disease more.

NCT ID: NCT03189849 Enrolling by invitation - Healthy Clinical Trials

Farms, Animals and Adolescents: Reinforcing the Microbiome

FAARM
Start date: June 2017
Phase: N/A
Study type: Observational

This study will be an observational study of children who attend summer camp at the Heartland Farm Sanctuary (HFS). The investigators are exploring whether time-limited exposure to a traditional farming environment will improve children's overall health and general well-being.

NCT ID: NCT03188302 Enrolling by invitation - Healthy Clinical Trials

Evaluation of New Method for Measuring Stool Consistency

Start date: June 2, 2017
Phase: N/A
Study type: Interventional

This study is designed to validate a new direct method for the measurement of stool consistency, using Texture Analyser. Forty healthy subjects are enrolled in this trial for collection of stool samples. Every stool produced during 2 collection periods of approximately 60 hours each is collected and subjected to the measurement of consistency using Texture Analyser. The stool consistency results are compared with the Bristol Stool Form Scale scores for each stool. The relationships of stool consistency with other stool parameters, bowel habit and sleeping habit are also evaluated.

NCT ID: NCT03146520 Enrolling by invitation - Healthy Clinical Trials

Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection

Start date: December 13, 2016
Phase: N/A
Study type: Observational

Pivotal trials of SDC2 methylation biomarker test in stool DNA to estimate clinical sensitivity and specificity in detection of colorectal cancer.

NCT ID: NCT03127046 Enrolling by invitation - Healthy Clinical Trials

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

DW6008
Start date: March 31, 2017
Phase: Phase 1
Study type: Interventional

To evaluate the drug-drug interaction between aceclofena and esomeprazole

NCT ID: NCT03076086 Enrolling by invitation - Healthy Clinical Trials

Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum

Start date: May 12, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to validate two new biomarkers in sputum samples. These are PiP3 (phosphoinositolphospat ) and phosphor proteins, representing important proteins within inflammatory situations of the lung.

NCT ID: NCT03044327 Enrolling by invitation - Healthy Clinical Trials

Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers

Start date: February 15, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to further profile and develop the Lipopolysaccharide, endotoxin (LPS) challenge models (both by instillation and inhalation) by investigating the utility of various non-invasive monitoring methods.

NCT ID: NCT03027518 Enrolling by invitation - Healthy Clinical Trials

WILD 5 Wellness: A 30-Day Intervention

Start date: February 6, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in Beloit College students. This program is called "WILD 5 Wellness: A 30-Day Intervention". Results for this study will be quantified through the use of standardized self-report questionnaires administered prior to and after students complete the WILD 5 program (Group 1) or 30 days of inactive participation (Group 2), and again approximately 30 days later when the initially inactive group (Group 2) will have just completed their active participation in the WILD 5 program and the first WILD 5 group (Group 1) will be approximately 30 days out from completion of their WILD 5 active portion. Data will be collected to evaluate participants' adherence and response to each element of WILD 5, a 5-pronged 30-day wellness intervention. It is expected that this 30-day integrated, prescriptive, and trackable program will be found to be an efficacious wellness intervention for Beloit College students as compared to the control (inactive) group of students not participating in the Active program.

NCT ID: NCT03024879 Enrolling by invitation - Healthy Clinical Trials

The Effect of Motilin on the Frequency and Amount of Food Intake

Start date: March 2014
Phase: Phase 4
Study type: Interventional

In this study, the investigators aimed at evaluating the role of motilin in the regulation of food intake. Motilin, a gastrointestinal hormone, is a hunger signal in healthy volunteers and is significantly increased in obese patients. Its role in food intake regulation might contribute to the pathogenesis of obesity.

NCT ID: NCT03005340 Enrolling by invitation - Healthy Clinical Trials

A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers

Start date: December 2016
Phase: Phase 1
Study type: Interventional

Randomized, open-label, single-dose, three-treatment, six-sequence, three-way crossover study to evaluate the safety and pharmacokinetic characteristics after coadministration of C1-R215 and C2-R215 compared to the administration of C1-R215 and C2-R215 independently in healthy male volunteers